PERSPECTA

News from every angle

← Back to headlines

LifeVantage outlines FY 2027 capex amid CEO transition

Health supplement company LifeVantage projected $3M-$3.5M in capital expenditures for fiscal 2027 while withholding formal guidance during a leadership transition.

28 Aug, 00:00 — 28 Aug, 00:00
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed18h ago

LifeVantage outlines FY 2027 capex at $3M-$3.5M while withholding formal guidance amid CEO transition

Read full article →

Related Stories

BYD Reports First Quarterly Profit Rise in Over a Year on Export Surge

31m ago

Fed Chair Warsh Signals Hawkish Stance on Inflation at Jackson Hole

33m ago

US-Mexico Trade Talks Stall Over Dispute on Cheese Names

1h ago

Walmart Reaches Settlement With U.S. Government Over Opioid Crisis

1h ago